Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Archives of Clinical Infectious Diseases
  4. Articles

  5. Colistin-Resistant Klebsiella pneumoniae: Prevalence of Integrons and Synergistic Out Turn for Colistin-Meropenem
  6. Scopus by Title (Ref)

Archives of Clinical Infectious Diseases

Infectious Diseases and Tropical Medicine Research Center, SBUMS

Home
Current IssueAccepted ManuscriptsAll IssuesIn PressSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsPublication Ethics and Malpractice StatementSupportContact UsReviewer and AE Registration FormOpen Peer Review (OPR)
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Prevalence of Integrons and mcr-mediated resistance among colistin-resistant Enterobacterales in hospitalized patients

- Elfeky D.S. , et al.

2. The Emergence of Carbapenem-Resistant Gram-Negative Bacteria in Mizoram, Northeast India

- Ralte V.S.C. , et al.

3. Phenotypic detection of hypermucoviscous phenotype in colistin-resistant klebsiella oxytoca from tamil nadu

- Shanthini T. , et al.

4. Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genes

- Moosavian M. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Publication Ethics and Malpractice Statement
  • Support
  • Contact Us
  • Reviewer and AE Registration Form
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.